Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Royal Bank of Canada (NY: RY )

103.37 +0.63 (+0.61%)
Official Closing Price Updated: 7:00 PM EST, Feb 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 558,459
Open 102.48
Bid (Size) 101.85 (1)
Ask (Size) 104.50 (1)
Prev. Close 102.74
Today's Range 102.14 - 103.90
52wk Range 83.63 - 116.84
Shares Outstanding 1,430,678,036
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Zimmer Biomet Beats on Earnings, Growth May be Priced In
Zimmer Biomet stock is gaining after beating expectations. However, ZBH stock was fairly valued before earnings meaning investors may need to wait on analysts 
Via MarketBeat
Why Is Royal Bank of Canada's Dividend So High?
The high yield on offer from the Royal Bank of Canada isn't shocking, but it is an opportunity for long-term investors. 
Via The Motley Fool

Performance

YTD
+10.36%
+10.36%
1 Month
+5.31%
+5.31%
3 Month
+7.89%
+7.89%
6 Month
+7.27%
+7.27%
1 Year
-10.15%
-10.15%

More News

Read More
3 Solid Blue-Chip Stocks to Buy on the Dip
Via InvestorPlace
Hopeful Golden Cross Forms On Royal Bank of Canada's Chart
Via Benzinga
Royal Bank of Canada: Dividend Insights
Via Benzinga
3 Incredibly Undervalued Growth Stocks to Buy Before They Heat Up
Via InvestorPlace
Earnings Outlook For Royal Bank of Canada
Via Benzinga
High Dividend 50: The Bank Of Nova Scotia
Via Talk Markets
5 Must-Buy Cryptos for Your January Buy List
Via InvestorPlace
Geron (NASDAQ: GERN) Reports Positive Results From IMerge Phase 3 Trial of Imetelstat for Lower Risk MDS
Via Spotlight Growth
Want to Collect a Dividend Every Month Next Year? Buy These 3 High-Yielding Stocks
Via The Motley Fool
Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services
Via Get News
BioMedNewsBreaks – Keros Therapeutics Inc. (NASDAQ: KROS) Presents Clinical and Preclinical Data from Its Lead Hematological Programs at 64th ASH Event
Via Investor Brand Network
KOMIPO Completed Construction of Concho Valley Solar Project in Texas
Via Newswire.com
Topics Economy Energy
Exposures Electricity Generation Supply Chain
Is Salesforce Stock a Bargain Down Here?
Via MarketBeat
These 2 Global Bankers Tout Attractive Yields That Have Been Growing For Years
Via Benzinga
Earnings Scheduled For November 30, 2022
Via Benzinga
Investors Liked These 2 Stock Buyouts Tuesday
Via The Motley Fool
Chesand Gregory Launches ‘Conscious Me’ To Empower Conscious And Ambitious Women
Via Get News
Chesand Gregory Launches ‘Conscious Me’ To Empower Conscious And Ambitious Women
Via Authority Press Wire
Green Impact Partners Progresses on Significant Milestones, Including Previously Announced Accretive Equity Process, GreenGas Colorado Commissioning, RNG Portfolio Advancements and Third Quarter 2022 Results
Via Newsfile
Topics Energy
Exposures Fossil Fuels
8 Dividend Stocks For Rising Interest Rates
Via Talk Markets
2 Growth Stocks That Could Soar 133% to 226% From Their 52-Week Lows, According to Wall Street
Via The Motley Fool
Chesapeake Energy Focus on Natural Gas Leads to Strong Results
Via MarketBeat
Topics Energy
Exposures Fossil Fuels
Will Shopify Stock Be Able to Improve Its Q3 E-commerce Performance While Facing Challenges?
Via PressReach
Topics Economy
Exposures Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.